A detailed history of Oup Management Co., LLC transactions in Precision Biosciences Inc stock. As of the latest transaction made, Oup Management Co., LLC holds 1,123,913 shares of DTIL stock, worth $5.06 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
1,123,913
Previous 1,123,913 -0.0%
Holding current value
$5.06 Million
Previous $595,000 35.8%
% of portfolio
0.86%
Previous 1.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

BUY
$7.4 - $11.66 $8.32 Million - $13.1 Million
1,123,913 New
1,123,913 $8.32 Million

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $499M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Oup Management Co., LLC Portfolio

Follow Oup Management Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oup Management Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oup Management Co., LLC with notifications on news.